Table 3 Changes in surrogate markers of liver fibrosis in HIV/HCV infection in the longitudinal analysis.
HCV genotype | 1 | non 1 | all | |||
|---|---|---|---|---|---|---|
IL28B genotype | CC n = 13 (33%) | CT n = 23 (59%) | TT n = 3 (8%) | all (n = 39) | all (n = 15) | all (n = 56) |
Change of Stiffness/month [k Pa/mo nth] | -0.08 ± 0.2 | 0.003 ± 0.4 | 0.2 ± 0.4 | -0.01 ± 0.4 | 0.04 ± 0.4 | 0.003 ± 0.4 |
Change of APRI/month | 0.001 ± 0.06 | 0.007 ± 0.05 | 0.006 ± 0.01 | -0.004 ± 0.05 | -0.06 ± 0.3 | -0.02 ± 0.1 |
Change of FIB-4/month | -0.01 ± 0.05 | 0.01 ± 0.07 | 0.02 ± 0.03 | 0.008 ± 0.06 | -0.04 ± 0.3 | -0.006 ± 0.2 |
Period [months] | 19 (5 - 48) | 27 (12 - 50) | 49 (14 - 50) | 22 (5 - 50) | 24 (9 - 47) | 25 (5 - 50) |